Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Nephrol. doi: /nrneph

Published by Modified over 5 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Nephrol. doi: /nrneph"— Presentation transcript:

1 Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.43
Figure 1 Recommendations for the renal and cardiac assessment of living kidney donor candidates Figure 1 | Recommendations for the renal and cardiac assessment of living kidney donor candidates. Donor candidates with borderline measurements of estimated glomerular filtration rate (eGFR), persistent isolated microscopic haematuria, or a moderate-to-high risk of perioperative cardiac events might warrant additional investigations. Donor candidates without these features can proceed with the donor evaluation process. CrCl, creatinine clearance; mGFR, measured glomerular filtration rate. Lam, N. N. et al. (2017) Renal and cardiac assessment of living kidney donor candidates Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Nat. Rev. Nephrol. doi: /nrneph"

Similar presentations

Trial profile Mann JF et al. Lancet 2008;372:547-53.

Trial profile Mann JF et al. Lancet 2008;372:
Figure 1 Schematic representation of idiopathic nephrotic syndrome,

Figure 1 Schematic representation of idiopathic nephrotic syndrome,
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),

Figure 4 Interplay between acute kidney injury (AKI),
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 6 Differences in glycaemic control with the study drug

Figure 6 Differences in glycaemic control with the study drug
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Similar presentations

Ads by Google